Eating a healthy diet, such as the Mediterranean diet, has a positive impact on health, but little is known about the effects of including unhealthy foods in an
Ping Identity has announced the appointment of Hall of Fame CIO Paul Martin to its board of directors.
Martin will help the security firm enhance its leadership strategy and IT innovation. He joins with a strong track record as an IT leader, having received a number of accolades. This includes being named to the CIO Hall of Fame by
CIO Magazine in 2017 and being awarded the 2020 Chicago CIO of the Year Leadership ORBIE Award.
His most recent position was as CIO and senior vice-president for healthcare company Baxter International Inc., where he was responsible for its global IT strategy, operations, security and processes. He has also held IT leadership roles at Rexam PLC, CIT Group, BNSF Railway and Frito-Lay Inc.
Physician Harassment Common on Social Media, Study Suggests medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Leadership demands corporate counsel in anticipation of a turbulent year.
Companies will face a daunting combination of challenges in 2021, brought on by globalization/nationalization, geopolitical risks, climate change, social justice, cybersecurity, and increased regulatory activity. What are the C-suiteâs expectations of the Office of the General Counsel in this environment? What demands will the GC need to balance in managing risk while enabling the pursuit of a new opportunity?
Join our senior executive panel for this webinar where you will learn what leaders anticipate they will need from their GC. Explore the challenges and strategies to meeting those expectations.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
CareDx Transplant Leadership Showcased at ASTS 2021
CareDx, Inc.January 8, 2021 GMT
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced it will be showcasing new transplant data at the upcoming 21st Annual American Society of Transplant Surgeons (ASTS) Digital Winter Symposium.
CareDx is sponsoring two symposia with key clinical leaders within transplantation, the speakers covering their real-world experiences using AlloSure to optimize care for their transplant patients, and highlighting novel data on the clinical utility of AlloSure. Of note, Dr. Jason Wellen will share initial data from the ADMIRAL study on AlloSure surveillance outcome